Jennifer A. Baird joined the board of directors of SeaStar Medical in 2024 and in July 2025 our Board of Directors appointed Ms. Baird as Chair of the Board of Directors. Ms. Baird brings leadership, management, and executive experience to provide effective support and oversight of the Company’s operations. Since 2023, Ms. Baird has served as the Executive Chair of the Board of Directors for Culturewell, Co., an organization that delivers actionable insights for healthcare infection prevention through environmental sampling testing and germ risk assessments. From 2017 to 2022, Ms. Baird founded and served as the Chief Executive officer of Fifth Eye Inc., a software medical device company developing and commercializing healthcare related clinical algorithms and predictive analytics using steaming physiologic parameter inputs. From 2010 to 2017, Ms. Baird was the chief executive officer of Accio Energy, Inc., an organization that focused on developing transformational renewable energy technology. In addition, Ms. Baird has co-founded other healthcare-based companies including Accuri Cytometers, Inc. (acquired by Becton Dickinson) and Sonetics Ultrasound, Inc. Ms. Baird served in Chief Executive Officer-Director roles for each of Fifth Eye, Inc., Accio Energy, Inc., Accuri Cytometers Inc., and Sonetics Ultrasound, Inc. Ms. Baird has served as a director for Hope Clinic, a nonprofit, since 2009 and an advisor for Michigan Founders Fund, since 2020.
Ms. Baird has a Bachelor of Arts in Organizational Psychology/Leadership from the University of Michigan and a Master of Business Administration from Kellogg Graduate School of Management Northwestern University.
What is Jennifer A. Baird's net worth?
The estimated net worth of Jennifer A. Baird is at least $16.74 thousand as of December 19th, 2025. Ms. Baird owns 3,620 shares of SeaStar Medical stock worth more than $16,735 as of October 2nd. This net worth approximation does not reflect any other assets that Ms. Baird may own. Learn More about Jennifer A. Baird's net worth.
How do I contact Jennifer A. Baird?
Has Jennifer A. Baird been buying or selling shares of SeaStar Medical?
Jennifer A. Baird has not been actively trading shares of SeaStar Medical during the last quarter. Most recently, on Friday, December 19th, Jennifer A. Baird bought 420 shares of SeaStar Medical stock. The stock was acquired at an average cost of $2.40 per share, with a total value of $1,008.00. Following the completion of the transaction, the director now directly owns 3,620 shares of the company's stock, valued at $8,688. Learn More on Jennifer A. Baird's trading history.
Who are SeaStar Medical's active insiders?
Are insiders buying or selling shares of SeaStar Medical?
In the last year, SeaStar Medical insiders bought shares 3 times. They purchased a total of 2,620 shares worth more than $8,535.50. The most recent insider tranaction occured on August, 18th when CFO Michael Messinger bought 750 shares worth more than $2,452.50. Insiders at SeaStar Medical own 0.7% of the company.
Learn More about insider trades at SeaStar Medical. Information on this page was last updated on 8/18/2026.